Early Life Adversity Alters the Developmental Profiles of Addiction-Related Prefrontal Cortex Circuitry

被引:51
|
作者
Brenhouse, Heather C. [1 ,2 ]
Lukkes, Jodi L. [2 ]
Andersen, Susan L. [2 ]
机构
[1] Northeastern Univ, Dept Psychol, 360 Huntington Ave, Boston, MA 02215 USA
[2] McLean Hosp, Belmont, MA 02478 USA
关键词
maternal separation; prefrontal cortex; dopamine receptors; nucleus accumbens;
D O I
10.3390/brainsci3010143
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Early adverse experience is a well-known risk factor for addictive behaviors later in life. Drug addiction typically manifests during adolescence in parallel with the later-developing prefrontal cortex (PFC). While it has been shown that dopaminergic modulation within the PFC is involved in addiction-like behaviors, little is known about how early adversity modulates its development. Here, we report that maternal separation stress (4 h per day between postnatal days 2-20) alters the development of the prelimbic PFC. Immunofluorescence and confocal microscopy revealed differences between maternally-separated and control rats in dopamine D1 and D2 receptor expression during adolescence, and specifically the expression of these receptors on projection neurons. In control animals, D1 and D2 receptors were transiently increased on all glutamatergic projection neurons, as well as specifically on PFC. nucleus accumbens projection neurons (identified with retrograde tracer). Maternal separation exacerbated the adolescent peak in D1 expression and blunted the adolescent peak in D2 expression on projection neurons overall. However, neurons retrogradely traced from the accumbens expressed lower levels of D1 during adolescence after maternal separation, compared to controls. Our findings reveal microcircuitry-specific changes caused by early life adversity that could help explain heightened vulnerability to drug addiction during adolescence.
引用
收藏
页码:143 / 158
页数:16
相关论文
共 50 条
  • [31] Stress and the adolescent brain Amygdala-prefrontal cortex circuitry and ventral striatum as developmental targets
    Tottenham, Nim
    Galvan, Adriana
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 70 : 217 - 227
  • [32] Early Life Adversity Arrests Prefrontal Cortical Maturation During Adolescence
    Tseng, Kuei
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 14 - 14
  • [33] Early Life Adversity Arrests Prefrontal Cortical Maturation During Adolescence
    Tseng, Kuei
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 14 - 14
  • [34] Stress & early life adversity: Biobehavioral mechanisms predicting addiction relapse
    al'Absi, Mustafa
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (12)
  • [35] Early life adversity: Epigenetic regulation underlying drug addiction susceptibility
    Winter, Julia J.
    Rodriguez-Acevedo, Kiara L.
    Dittrich, Mia
    Heller, Elizabeth A.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2023, 125
  • [36] Early Life Stress Alters Gene Expression and Cytoarchitecture in the Prefrontal Cortex Leading to Social Impairment and Increased Anxiety
    Usui, Noriyoshi
    Ono, Yuta
    Aramaki, Ryoko
    Berto, Stefano
    Konopka, Genevieve
    Matsuzaki, Hideo
    Shimada, Shoichi
    FRONTIERS IN GENETICS, 2021, 12
  • [37] Dorsal medial prefrontal cortex (MPFC) circuitry in rodent models of cocaine use: implications for drug addiction therapies
    Jasinska, Agnes J.
    Chen, Billy T.
    Bonci, Antonello
    Stein, Elliot A.
    ADDICTION BIOLOGY, 2015, 20 (02) : 215 - 226
  • [38] CB1 Agonism Alters Addiction-Related Behaviors in Mice Lacking Mu or Delta Opioid Receptors
    Roeckel, Laurie-Anne
    Massotte, Dominique
    Olmstead, Mary C.
    Befort, Katia
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [39] The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience
    al'Absi, Mustafa
    STRESS AND BRAIN HEALTH: IN CLINICAL CONDITIONS, 2020, 152 : 71 - 100
  • [40] Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction
    Al'Absi, Mustafa
    Ginty, Annie T.
    Lovallo, William R.
    NEUROPHARMACOLOGY, 2021, 188